ENTITY

Mesoblast Ltd (MSB AU)

Analysis

Health Care • Australia

Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.

Refresh

Focused

No publications yet

Add Mesoblast Ltd to your Watchlist to get alerts on new publications

Add to Watchlist

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00